AMBER CATLIN: Open Payments
NPI 1912351701 · HENDERSON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,942 in 88 payments from 28 companies in 2025. Trend: 2023 $144 · 2024 $603 · 2025 $1,942
Food & beverage: $1,942
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 15 | $312 |
| PFIZER INC. | 13 | $224 |
| Novartis Pharmaceuticals Corporation | 9 | $194 |
| PharmaEssentia USA Corporation | 6 | $139 |
| Janssen Biotech, Inc. | 3 | $85 |
| Ipsen Biopharmaceuticals, Inc | 3 | $85 |
| PUMA BIOTECHNOLOGY, INC. | 4 | $69 |
| Gilead Sciences, Inc. | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $67 |
Products named: KEYTRUDA, BESREMI, PADCEV, Onivyde, IBRANCE, NERLYNX, SCEMBLIX, LIBTAYO.
Industry payments across KY — which companies pay providers there.
